This email notification is intended as a heads up to OHSU communicators. It is not shared with external subscribers.
|
New clinical trial at OHSU tests donated antibodiesNationwide clinical trial finds no significant benefit in using convalescent plasma for early treatment of COVID-19.
|
|
This email was sent to you by Oregon Health & Science University 3181 S.W. Sam Jackson Park Rd. | Portland, Oregon 97239-3098 |